Meet the Real-Life Loves of the Original “SNL” Cast

The first cast of SNL comprised of Chevy Chase, Jane Curtin, Garrett Morris, John Belushi, Laraine Newman, Gilda Radner and ...
Coeur d'Alene Press

Marlene Claudia Wogsland, 91

Wogsland passed away peacefully, surrounded by her family, on Sept. 26, 2025, at the age of 91. Born March 17, 1934, in Billings, Mont., to Dorothy and Bill Clark, ...
The Caledonian-Record

Robin Lynn Heywood Obituary

Robin Lynn Heywood, 52, passed away peacefully on Wednesday, September 10, 2025, at Dartmouth-Hitchcock Medical Center in ...

Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis

Gyre Therapeutics (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today ...

SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmace…

According to the agreement, SciSparc’s pharmaceuticals assets and equity stake in SciSparc Nutraceuticals Inc. are valued at ...

Gyre Therapeutics Inc.: Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis

Gyre Therapeutics (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems ...

Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase 3 Results in Primary Sjögren ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.
Novartis

Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients 1-3 Fabhalta is first and only approved complement inhibitor for ...

The SIM Card Attack No One’s Ready For – And the SMX Technology That Can Stop It (NASDAQ: SMX)

NEW YORK, NY / ACCESS Newswire / October 8, 2025 / History is full of moments when the world came dangerously close to ...

SciSparc Ltd: SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage ...

According to the agreement, SciSparc's pharmaceuticals assets and equity stake in SciSparc Nutraceuticals Inc. are valued at approximately US$11.6 million TEL AVIV, Israel, Oct. 15, 2025 (GLOBE NEWSWI ...
PharmiWeb

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically ...

DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...
MotorTrend on MSN

What Is a Catfish Camaro? Unpopular Design at the Time, Cool Now

Midway through its production, the fourth-generation Chevy Camaro got a facelift. It wasn’t that popular, but it packed a ...